Akèy › Obèsite › Montana › Missoula

Etid klinik pou Obèsite nan Missoula, MT

5 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Missoula (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi

ACCOMPLISH-2 Research Site, Missoula

Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3

Kailera Clinical Site, Missoula

Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Ap rekriteFaz 3

Kailera Clinical Site, Missoula

Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07284979

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Ap rekriteFaz 3

Montana Medical Research, Missoula

Laj 18 a 99 · Tout sèks · Mizajou Aug 27, 2026 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Ap rekriteFaz 3

ACCOMPLISH-1 Research Site, Missoula

Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361

Etid Obèsite nan lòt vil

Lòt etid nan Missoula

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.